The Interconnection Between Pharmaceutical Development and Preclinical Research (Review)
Introduction. Pharmaceutical development of an innovative highly effective and competitive drug is a long and expensive process, the result of which is quite difficult to predict in advance. To speed up the entry of a new drug to the treatment and reduce the developer's material costs, it is ad...
Saved in:
| Main Authors: | I. N. Ampilogova, M. V. Karlina, V. G. Makarov, M. N. Makarova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
2023-05-01
|
| Series: | Разработка и регистрация лекарственных средств |
| Subjects: | |
| Online Access: | https://www.pharmjournal.ru/jour/article/view/1495 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ANALYTICAL REVIEW OF THE NORMATIVE BASE TO PROVIDE THE GOOD QUALITY OF PRECLINICAL STUDIES IN RUSSIA
by: A. I. Selezneva, et al.
Published: (2019-01-01) -
Endocrine Disorders Associated with Medicinal Products: Approaches to Preclinical Safety Assessment
by: K. L. Kryshen, et al.
Published: (2023-03-01) -
The Modern Concepts of Pharmaceutical Development in the Context of the Transition to a Uniform Regulation of Medicinal Products Circulation
by: A. E. Feofilova, et al.
Published: (2020-11-01) -
Dose Selection in Preclinical Studies: Cross-Species Dose Conversion
by: E. V. Shekunova, et al.
Published: (2020-02-01) -
Documentation of Pharmaceutical Development. Part 2. Quality System Documents
by: I. E. Smekhova, et al.
Published: (2021-05-01)